Seroprevalence of Hepatitis B and Hepatitis C among Men Visiting a Selected Health Facility in Ado-Ekiti, Ekiti State

As a viral infection targeting the liver, hepatitis poses significant risks, including the potential progression to cirrhosis, hepatic failure, and hepatocellular carcinoma. Hepatitis B (HBV) and Hepatitis C (HCV) persist as critical public health concerns, predominantly in developing regions characterized by insufficient screening programs, vaccination coverage, and disease awareness. This study determines the prevalence of Hepatitis B and Hepatitis C among men attending Oke Iyimi Health Facility, Ado-Ekiti, Ekiti State, Nigeria, and it identifies the rate of co-infection within the study population. A cross-sectional study design was employed. Venous blood samples (n = 138) were collected from male participants. Plasma samples were analyzed using Promed® rapid diagnostic test kits for the detection of Hepatitis B surface antigen (HBsAg) and Hepatitis C virus antibody (anti-HCV). Data were analyzed using Microsoft Excel and SPSS version 26. Results showed that 12 participants (8.7%) tested positive for HBV, while 1 participant (0.7%) tested positive for HCV. The only HCV positive patient was also HBV-positive, indicating one case of HBV/HCV co-infection. The highest HBV positivity occurred among participants aged 31–40 years (15.4%), followed by 21–30 years (13.5%) and 51–60 years (6.3%). The HCV infection (0.7%) was observed in the 21–30 years age group. Based on these findings, it is recommended that routine screening for viral hepatitis be intensified at the community and primary healthcare levels. Public health education, vaccination programs, and awareness campaigns should also be strengthened to promote early detection, prevention, and control of Hepatitis B and C infections among men.

Hepatitis B, Hepatitis C, Men, Ado Ekiti

1. Ajayi O.D., and Omon E.A.(2022). Seroprevalence of Hepatitis B and C Viruses Among Young Prospective Blood Donors in Bamidele Olumilua University of Education, Science and Technology (Bouest), Ikere, Ekiti State, Nigeria. International Journal of Scientific Research and Engineering Development 5:2. [Google Scholar] [Crossref]

2. Ajuwon, B.I., Yujuico, I., Roper, K., Richardson, A., Sheel, M., & Lidbury, B.A., (2021). Hepatitis B virus infection in Nigeria: A systematic review and meta-analysis of data published between 2010 and 2019. BioMed Central Infectious Diseases, 21(1), 1120. https://doi.org/10.1186/s12879-021-06800-6 [Google Scholar] [Crossref]

3. Akindigh, T.M., Joseph, A.O., Robert, C.O., Okojokwu, O.J., Okechalu, J.N., and Anejo‑Okopi, J.A., (2019). Seroprevalence of hepatitis B virus co‑infection among HIV‑1‑positive patients in North‑Central Nigeria: The urgent need for surveillance. African Journal of Laboratory Medicine, 8(1), Article 622. https://doi.org/10.4102/ajlm.v8i1.622 [Google Scholar] [Crossref]

4. Easterbrook, P. J., & WHO Guidelines Development Group (2016). Who to test and how to test for chronic hepatitis C infection - 2016 WHO testing guidance for low- and middle-income countries. Journal of hepatology, 65(1 Suppl), S46–S66. https://doi.org/10.1016/j.jhep.2016.08.002 [Google Scholar] [Crossref]

5. Famoni O. P., Oyinloye J. M. A., Okiki P. A., Daramola G. O., Ojerinde A. O., and Ajayi O. D. (2024). Prevalence of HBV Co-infections with HCV and HIV among Blood Donors in Ado-Ekiti, Ekiti State, Nigeria. Journal of Advances in Microbiology.24:5, Pp 6-17 [Google Scholar] [Crossref]

6. Hebo, H.J., Gemeda, D.H., and Abdusemed, K.A., (2019). Hepatitis B and C viral infection: Prevalence, knowledge, attitude, practice, and occupational exposure among healthcare workers of Jimma University Medical Center, Southwest Ethiopia. The Scientific World Journal, 2019, Article ID 9482607. https://doi.org/10.1155/2019/9482607 [Google Scholar] [Crossref]

7. Kassim, O.D., Oyekale, T.O., Aneke, J.C.O., and Durosinmi, M.A., (2014). Prevalence of seropositive blood donors for hepatitis B, C and HIV viruses at Federal Medical Centre, Ido-Ekiti, Nigeria. Annals of Tropical Pathology Vol. 5:2 [Google Scholar] [Crossref]

8. Lawal, M.A., Adeniyi, O.F., Akintan, P.E., Salako, A.O., Omotosho, O.S., & Temiye, E.O., (2020). Prevalence of and risk factors for hepatitis B and C viral co-infections in HIV infected children in Lagos, Nigeria. PLoS ONE, 15(12), e0243656. https://doi.org/10.1371/journal.pone.0243656 [Google Scholar] [Crossref]

9. Musa, B.M., Bussell, S., Borodo, M.M., Samaila, A.A., & Femi, O.L., (2015). Prevalence of hepatitis B virus infection in Nigeria, 2000–2013: A systematic review and meta-analysis. Nigerian Journal of Clinical Practice, 18(2), 163–172. https://doi.org/10.4103/1119-3077.151035 [Google Scholar] [Crossref]

10. Odukoya, O., Odeyemi, K., Odubanjo, O., Isikekpei, B., Igwilo, U., Disu, Y., Roberts, A., Olufunlayo, T., Kuyinu, Y., Ariyibi, N., Eze, U., Awoyale, T., Ikpeekha, O., Odusanya, O., & Onajole, A., (2022). Hepatitis B and C seroprevalence among residents in Lagos State, Nigeria: A population-based survey. Nigerian Postgraduate Medical Journal, 29(2), 75–81. https://doi.org/10.4103/npmj.npmj_776_21 [Google Scholar] [Crossref]

11. Ojerinde, O.A., Ojo, S.K.S., Udewena, U. L, and Oladeji, S.J., (2023). A cross-sectional study on the prevalence of HIV and hepatitis B virus co-infection among students of a tertiary institution in Ekiti State, Southwest Nigeria. Pan African Medical Journal, 44, 7. [Google Scholar] [Crossref]

12. https://doi.org/10.11604/pamj.2023.44.7.31416 [Google Scholar] [Crossref]

13. Okonkwo, U.C., Okpara, H., Otu, A., Ameh, S., Ogarekpe, Y., Osim, H., & Inyama, M., (2017). Prevalence of hepatitis B, hepatitis C and human immunodeficiency viruses, and evaluation of risk factors for transmission: Report of a population screening in Nigeria. South African Medical Journal, 107(4), 346–351. https://doi.org/10.7196/SAMJ.2017.v107i4.12198. [Google Scholar] [Crossref]

14. Olayinka, A.T., Oyemakinde, A., Balogun, M.S., Ajudua, A., Nguku, P., Aderinola, M., Egwuenu-Oladejo, A., Ajisegiri, S.W., Sha’aibu, S., Musa, B.O., Gidado, S., & Nasidi, A., (2016). Seroprevalence of hepatitis B infection in Nigeria: A national survey. American Journal of Tropical Medicine and Hygiene, 95(4), 902–907. https://doi.org/10.4269/ajtmh.15-0874 [Google Scholar] [Crossref]

15. Omolade, O., and Adeyemi, A., (2018). Prevalence of hepatitis C virus antibody among university students in Nigeria. Journal of Virus Eradication, 4, 228–229. https://doi.org/10.1016/S2055-6640(20)30307-1 [Google Scholar] [Crossref]

16. Spearman, C.W., Afihene, M., Ally, R., Apica, B., Awuku, Y., Cunha, L., and Sonderup, M. W., (2017). Hepatitis B in sub‑Saharan Africa: Strategies to achieve the 2030 elimination targets. The Lancet Gastroenterology and Hepatology, 2(12), 900–909. [Google Scholar] [Crossref]

17. https://doi.org/10.1016/S2468-1253(17)30295-9 [Google Scholar] [Crossref]

18. Tesfaye, S., Alemu, A., Bizualem, E., Mehabie, D., and Alelign, A., (2024). Seroprevalence of hepatitis B, C, and its associated risk factors among clinically suspected patients attending Poly and Maraki Health Centers, Gondar City, North West Ethiopia. SAGE Open Medicine, 12, 1–11. https://doi.org/10.1177/20503121241266347 [Google Scholar] [Crossref]

19. Wallace, J., Pitts, M., Liu, C., Lin, V., Hajarizadeh, B., Richmond, J., and McNally, S., (2017). More than a virus: A qualitative study of the social implications of hepatitis B infection in China. International Journal for Equity in Health, 16, Article 137. https://doi.org/10.1186/s12939-017-0637-4 [Google Scholar] [Crossref]

20. World Health Organization (WHO)., (2024). Hepatitis C—Key facts. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c [Google Scholar] [Crossref]

21. World Health Organization., (2020a). Hepatitis. [Google Scholar] [Crossref]

22. https://www.who.int/health‑topics/hepatitis#tab=tab\_1 [Google Scholar] [Crossref]

23. World Health Organization., (2020b). Hepatitis B. [Google Scholar] [Crossref]

24. https://www.who.int/news‑room/fact‑sheets/detail/hepatitis‑b [Google Scholar] [Crossref]

25. World Health Organization., (2020c). Hepatitis C. [Google Scholar] [Crossref]

26. https://www.who.int/news‑room/fact‑sheets/detail/hepatitis‑c [Google Scholar] [Crossref]

27. World Health Organization., (2021). WHO releases first-ever global guidance for country validation of viral hepatitis B and C elimination. https://www.who.int/news/item/25-06-2021-who-releases-first-ever-global-guidance-for-country-validation-of-viral-hepatitis-b-and-c-elimination [Google Scholar] [Crossref]

28. World Health Organization., (2022). Hepatitis B fact sheet. World Health Organization. [Google Scholar] [Crossref]

29. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b [Google Scholar] [Crossref]

30. World Health Organization., (2023). Hepatitis. https://www.who.int/health-topics/hepatitis#tab=tab\_1 [Google Scholar] [Crossref]

• Measuring Waste of Patient Time in Health Care at Non-Digitized Hospital: An Observational Study in Bangabandhu Sheikh Mujib Medical University, Bangladesh
• Reaffirming Clinical Confidence in Atorvastatin Therapy: A Digital Outreach Case Study from Tamil Nadu, India
• Clinical Manifestations and Therapeutic Response in a Patient with Hypothyroidism: A Case Report
• Eranda (Ricinus Communis) In Gridhrasi (Sciatica): Classical Rationale, Pharmacology and Clinical Evidence- A Narrative Literature Review
• Magnetotherapy in Pain Management: Mechanisms, Clinical Applications, and Future Perspectives – A Review